⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for immunologic response

Every month we try and update this database with for immunologic response cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
To Detect Cryoimmunologic Response Induced by Early Breast Cancer Ultrasound-guided Cryoablation (ICE-study)NCT05727813
Cancer, Treatme...
Tumor of Breast
Systemic Inflam...
Stage I Breast ...
cryoablation
18 Years - University of Roma La Sapienza
The Correlation Between the Haplotype of Human Leukocyte Antigen (HLA) and Human PapillomavirusNCT00154479
Cancer of Cervi...
18 Years - 80 YearsNational Taiwan University Hospital
Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic MelanomaNCT00314106
Metastatic Mela...
Melanoma Reacti...
Cyclophosphamid...
IL-2
Fludarabine
1200 total body...
18 Years - National Institutes of Health Clinical Center (CC)
Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk MelanomaNCT00273910
High-Risk Melan...
gp100:209-217 (...
Montanide ISA-5...
Imiquimod
7 Years - National Institutes of Health Clinical Center (CC)
Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk MelanomaNCT00273910
High-Risk Melan...
gp100:209-217 (...
Montanide ISA-5...
Imiquimod
7 Years - National Institutes of Health Clinical Center (CC)
Peptide Vaccination for Patients at High Risk for Recurrent MelanomaNCT00059475
Melanoma
Glycoprotein 10...
Interleukin-2 (...
Montanide ISA 5...
Melanoma antige...
27-35 (27L): me...
melanoma antige...
7 Years - National Institutes of Health Clinical Center (CC)
Chemotherapy, Irradiation, Cell Infusions, and Interleukin-2 to Treat Metastatic MelanomaNCT00314106
Metastatic Mela...
Melanoma Reacti...
Cyclophosphamid...
IL-2
Fludarabine
1200 total body...
18 Years - National Institutes of Health Clinical Center (CC)
Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in MelanomaNCT01363206
Malignant Melan...
Granulocyte-Mac...
Ipilimumab
18 Years - Northern California Melanoma Center
Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in MelanomaNCT01363206
Malignant Melan...
Granulocyte-Mac...
Ipilimumab
18 Years - Northern California Melanoma Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: